Ligand Pharmaceuticals Logo

Ligand Pharmaceuticals

🇺🇸
LGND
US53220K5048

Ligand Pharmaceuticals is a biopharmaceutical company that develops and markets innovative medicines. Through its unique licensing model, Ligand focuses on identifying, acquiring, and developing promising therapeutics for treating various diseases. The company strengthens its pipeline and generates revenue through partnerships with leading pharmaceutical companies.

Next Quarterly Earnings

Tuesday, August 11, 2026
CW 33
Pre-Market
In 37 days

Stock Price

All Dates

Company Information

Name
Ligand Pharmaceuticals
Ticker Symbol
LGND
ISIN
US53220K5048
Country
🇺🇸
USA